Home About Us Contact Us

 

Table of Content - Volume 14 Issue 3 - June 2020

 

Preparation of vagina with povidone iodine before caesarean section to reduce postoperative morbidity

 

Ranu Singh Kushwaha1, Khushboo Yasmin2*

 

1,2Junior Residents, Department of Gynecology, Darbhanga Medical College and Hospital, Darbhanga, Bihar, INDIA.

Email: drkhushboo.yasmin@gmail.com

 

Abstract Background: Clinical practice of medicine have used numerous strategies to combat wound infections, including topical and systemic administration of antibiotics, and various antiseptic agents such as hypochlorite and hydrogen peroxide have been placed on wounds to kill bacteria or inhibit their growth. A commonly used antimicrobial agent is povidone-iodine, a complex of iodine, the bactericidal component, with polyvinylpyrrolidone (povidone), a synthetic polymer. Povidone-iodine is available as a surgical scrub or skin cleanser with a detergent base or in other forms, the effect of povidoneiodine on several of the cellular components of the wound healing mechanism. Methodology: It was Interventional and randomised, Parallel Assignment study. The study was conducted among the women undergoing elective and emergency caesarean section in our Darbhanga Medical College and Hospital. The recruitment target is being kept at 50 subjects per group. The study period was January 2018 to May 2019. Caesarean section was done in the department of Obstetrics and Gynaecology of Darbhanga Medical College and Hospital. Results: The age of our study subjects ranged between 18-33 years. The mean age of the case and control group was 25.700 ±2.45 and 26.300 ± 2.80 respectively. Above analysis for age distribution in both groups we found no significance (p value 0.36). The mean intra operative time of both groups is mentioned. The mean value of intra operative time for case and control group was 37.040 ±1.92 and 37.020 ±1.95. Above analysing the mean intra operative time of two groups we found no statistical significance (p value = 0.762). The common morbidity was fever involving total 18 patients among them 4 belonged to case group and 12 belonged to control group followed by endometritis involving 13 patients among them 03 belonged to case group and 10 belonged to control group; wound infection involving 16 patients among them 2 belonged to case group and 14 belonged to control group. the least common morbidity was sepsis found in 10 patients among them 3 belonged to case group and 7 belonged to control group. Statistical significance found in wound infection and endometritis while analysing. Conclusion: We observed the occurrence of endometritis can be reduced while preparing the vagina preoperatively with Povidone Iodine compared to those who received vaginal scrub only.

Key Word: povidone iodine.

 

INTRODUCTION

A surgical site infection is defined as an infection which occurs at the incision / operative site (including drains) within 30 days after surgical operation if no implant is left in place / within 1 year if an implant is left in place. The infection must appear to be related to the surgical procedure1. According to CDC’s National Nosocomial Infection Surveillance system 38% of all nosocomial infections in surgical patients are surgical site infections (SSI). They constitute third most common nosocomial infection. Surgical site infections delay recovery, prolong hospitalization or outpatient treatment, may necessitate readmission, increase hospital bills as well as other morbidities and mortality2, thus are responsible for significant psychological and economic burden to the society. The rate of surgical site infection after caesarean section range from 3% to 15%, depending on the surveillance methods used to identify infections, the patient population, and the use of antibiotic prophylaxis3-5. The causes of surgical site infection following caesarean section are universal with only slight regional variations6. Intrinsic factors are patient related and include age, obesity, underlying medical conditions like diabetes mellitus, hypertension, asthma, immunocompromised states like HIV infection, hypoalbuminemia, hyperlipidemia, anemia. Extrinsic factors relate to the management and care, which include preoperative preparation of the patient (part preparation and skin asepsis), type of procedure (emergency/elective), type of anaesthesia (regional/general), type of skin incision (horizontal/vertical), method of skin closure, type of suture used (mono/ polyfilament) or use of staples, antibiotic prophylaxis, length of time membranes ruptured prior to operation, manual extraction of placenta, chorioamnionitis, number of vaginal examinations carried out before surgery, duration of operation, transfusion of blood products, grade of operator (consultant/registrar/senior resident), previous caesarean section, and environment of the operating room7. Knowledge of risk factors associated with surgical site infection is essential to develop targeted prevention strategies and reduce the risk of infection. Surgical site infection frequently affects the superficial tissues, but some serious infections affect the deeper tissues or other parts of the body manipulated during the procedure. Majority of surgical site infections become apparent within 30 days of an operative procedure and most often between the 5th and 10thpostoperative days. The CDC definition8 describes three levels of surgical site infection; ‘Superficial incisional’ affecting the skin and subcutaneous tissue, ‘Deep incisional’, which affects the fascial and muscle layers and ‘Organ or Space infection’ which involves any part in the body other than the incision that is opened or manipulated during the surgical procedure. This review found that cleansing the vagina with an antiseptic solution immediately before the cesarean delivery reduced the risk of post-cesarean infection of the uterus (womb) (low quality of evidence). The benefit was greater if the woman’s water had already broken (the membranes had ruptured) or if they were already in labor at the time of the cesarean delivery. This review did not find that vaginal cleansing reduced the number of women experiencing fever or wound complications after cesarean delivery. The antiseptic was povidone-iodine, and no adverse events such as allergy or irritation were noted in any of the seven randomized trials, reporting on 2635 women, from vaginal preparation solution.

 

METHODS

It was Interventional and randomised, Parallel Assignment study. The study was conducted among the women undergoing elective and emergency caesarean section in our Darbhanga Medical College and Hospital. The recruitment target is being kept at 50 subjects per group. The study period was January 2018 to May 2019. Caesarean section was done in the department of Obstetrics and Gynaecology of Darbhanga Medical College and Hospital.

Inclusion criteria:

The study was open to all pregnant women who were to undergo a cesarean delivery over age 18 years and able to give informed consent.

Exclusion criteria:

Exclusion from enrolment was related solely to medical contraindications to the vaginal preparation required for the trial, including :

  1. Highly emergent caesarean
  2. Planned cesarean hysterectomy
  3. Allergy to povidone iodine, iodine, or shellfish
  4. Bleeding placenta previa;
  5. Active genital herpes.
  6. Pregnancy with diabetes

Sample Size:

Sample size estimation was done based on a 10% absolute difference in fever rate between the two study groups, assuming 15% fever incidence in control group and 5% in povidone iodine group. It was estimated that 141 subjects would be required per group in order to detect such a difference with 80% power and 5% probability of type I error. Assuming a 15% non-evaluable record rate, the recruitment target is being kept at 50 subjects per group

Case group: The intervention group was received vaginal scrub before caesarean section. The vaginal scrub was consisting of 3 sponge sticks soaked in 5% povidoneiodine. The vaginal scrub encompassed the vaginal apex to the introitus with attention to the anterior, posterior, and lateral walls including all fornices.

Control group: The control group was received the standard abdominal scrub, only, without the vaginal preparation with povidone iodine

Outcome definition and parameters:

Fever : defined as temperature of 38°C or greater excluding the first day after caesarean.

Endometritis: defined as uterine tenderness plus postoperative feverrequiring additional antibiotic administration.

Wound complications: defined as incisional infection requiring antibiotics,separation, seroma, hematoma, or requirement for debridement. These were clinical diagnoses and require documentation by the care provider inthe chart. Chorioamnionitis was defined as fever (defined by the manifestation of a maternal temperature greater than 38°C) during labor along with clinicalsigns of infection (fundal tenderness, tachycardia, purulent lochia, etc)


RESULTS

Table 1: Distribution of age among case and control group

Age

Case group (n=50)

Control group (n=50)

p Value

18 - 33 years

Mean

SD

Mean

SD

0.365

25.759

±2.726

25.945

±2.66

 

Table 2: Preoperative analysis

Gestational age at delivery

(Weeks)

Case group (n=50)

Control group (n=50)

p Value

Mean

SD

Mean

SD

0.087

39.332

±0.88

39.236

±1.06

Parity

1.700

±0.67

1.740

±0.69

0.953

BMI

26.432

±2.13

29.180

±1.78

0.107

 

Table: 3. Distribution of Labour status (b) among case and control group

Labour status

Case group (n=50)

Control group (n=50)

p Value

 

Mean

SD

Mean

SD

Pelvic Examination

5.210

±1.15

4.800

±1.16

0.64

Length of membranes ruptured

(Hour)

7.180

±1.49

7.800

±1.22

0.03

 

Table: 4: Intra-operative analysis among case and control group

Intra-operative Time (min)

Case group

(n=50)

Control group (n=50)

p Value

 

Mean

SD

Mean

SD

37.040

±1.92

37.020

±1.95

0.76

Intra-operative blood loss (ml)

688.600

±68.49

701.800

±71.41

070

 

Table: 5: Postoperative infectious morbidities among Case and Control group

Infectious morbidities

Case group

(n=50)

Control group (n=50)

p Value

 

No

Percentage

No

Percentage

Fever

4

8

12

24

0.02

Sepsis

03

6

07

14

0.15

Wound Infection

02

4

14

28

0.01

Endometritis

3

6

10

20

0.03

 

Table: 6. Neonatal outcomes among Case and Control group

Neonatal

outcomes

Case group (n=9)

Control group (n=15)

p Value

 

Mean

SD

Mean

SD

Birth weight

(gm)

3001.047

±22.25

2975.114

±19.67

0.06

Apgar score at 1 min

8.222

±0.77

8.321

±0.79

0.86

5 min Apgar score

9.204

±0.55

9.546

±0.67

0.17

NICU length of stay

(Days)

6.200

±1.11

6.240

±1.17

0.41

 

No of Patients

Percentage

No of Patients

Percentage

p Value

Apgar score <7

4

8

6

12

0.67

NICU Admission

12

24

21

42

0.23

 


DISCUSSION

Pre operative analysis:

The age of our study subjects ranged between 18-33 years. The mean age of the case and control group was 25.700 ±2.45 and 26.300 ± 2.80 respectively. Above analysis for age distribution in both groups we found no significance (p value 0.36).

Pre portative analysis of both case and control group and their comparison is tabulated in this section. In this study, mean gestational age of both case and control group at the time of delivery. The mean gestational age of case and control group was 39.332±0.88 and 39.236±1.06 respectively. While analyzing gestational age in both groups we found no statistical significance (p value = 0.08).

We have found the mean and SD value of BMI for case and control group is 26.432 ±2.13 and 29.180 ±1.78 respectively. Above analysing the mean BMI we found no statistical significance.

The mean number of pelvic examination for case and control group was 5.210 ±1.15 and 4.800 ±1.16 respectively. The p value (0.64) we found was no statistically insignificant. The mean duration of membrane rupture for case and control group was 7.180 ±1.49 and 7.800±1.22 respectively. While analysing the duration of membrane rupture we found statistical significance (p value = 0.039).

Recent studies have investigated specific preoperative interventions to decrease the risk of postcesarean endometritis. One published study also investigated the use of preoperative vaginal preparation with povidone-iodine before cesarean delivery.

Reid et al.9 reported that vaginal preparation did not affect the incidence of postoperative fever, endometritis, or wound infection. However, that study did not address several potential risks for increased exposure to infection, specifically, a history of antenatal genitourinary infection, use of intrapartum internal monitors, severe anemia, or presence of obesity.

Intra operative analysis

The mean intra operative time of both groups is mentioned. The mean value of intra operative time for case and control group was 37.040 ±1.92 and 37.020 ±1.95. Above analysing the mean intra operative time of two groups we found no statistical significance (p value = 0.762).

We shows the mean intra operative blood loss level in case and control group. The mean intra operative blood loss level for case and control group was 688.600 ±68.49 and 701.800 ±71.41 While analysing the p value (0.707) we found no statistical significance.

Post operative analysis

In our study, the common morbidity was fever involving total 18 patients among them 4 belonged to case group and 12 belonged to control group followed by endometritis involving 13 patients among them 03 belonged to case group and 10 belonged to control group; wound infection involving 16 patients among them 2 belonged to case group and 14 belonged to control group. the least common morbidity was sepsis found in 10 patients among them 3 belonged to case group and 7 belonged to control group. Statistical significance found in wound infection and endometritis while analysing.

Osborne and Wright (1977)10 showed that povidone-iodine scrub could reduce 48% of vaginal bacteria. Vaginal scrub can reduce anaerobic Gram-positive rods, Gram-negative rods and some anaerobes and facultative coccus, specifically enterococci.

Our findings are in agreement with Guzman and colleagues (2002)11, who demonstrated that vaginal preparation prior to caesarean section can reduce endometritis (p50.04),

We confirmed the study of Starr et al. (2005)12 that vaginal scrub with povidone-iodine prior to operation can reduce endometritis. Our findings are in accordance with Eason and colleagues’ (2004)13 study on 1,570 TAHs, that the risk of pelvic abscesses was reduced by vaginal povidone-iodine gel use. Reid et al.9 reported that vaginal preparation did not affect the incidence of postoperative fever, endometritis, or wound infection. However, that study did not address several potential risks for increased exposure to infection, specifically, a history of antenatal genitourinary infection, use of intrapartum internal monitors, severe anemia, or presence of diabetes mellitus or obesity. Also, that study did not indicate whether all participants received parenteral prophylactic antibiotic at the time of umbilical cord clamping. vaginal antiseptic preparation using povidone iodine was used prior to cesarean section procedures and was found to reduce the risk of postpartum endometritis (Haas et al., 2014)14. Hass and Co- workers concluded that vaginal preparation with povidone-iodine solution immediately before cesarean delivery reduces the risk of post-operative endometritis (Haas et al., 2014)14 Neonatal outcome of both groups is mentioned. Mean birth weight of newborns of case and control group was 3001.047 ±22.25 and 2975.114 ±19.67 respectively with ap value of 0.06 while analysing which is statistically insignificant. Total 24 newborns had a admission at NICU among them 9 belonged to case group and 15 belonged to control group. While analysing we found the p value (0.06) statistically insignificant. Mean Apgar score at 1 minute for case and control group was 8.222±0.77 and 8.321±0.79 respectively with a p value of 0.86 which is statistically not significant. The mean Apgar score at 5 minutes was 9.240 ±0.55 and 9.456 ±0.67 with a p value of 0.17 which is statistically insignificant. <7 Apgar score was observed in 10 newborns among them 4 belonged to case group and 6 belonged to control group.

 

CONCLUSION

Our study showed the benefit of a preoperative vaginal preparation just before caesarean delivery. The incidence of post-caesarean endometritis significantly decreased in those subjects who were scrubbed with both abdominal and vaginal povidone-iodine, prepared with those who received a standard abdominal scrub alone. Vaginal povidone-iodine preparation may reduce the occurrence of post-caesarean wound infection and endometritis.

 

REFERENCES

  1. Bruce, J., Russel, EM., Mollison, J. The Measurement and Monitoring of Surgical Adverse Events. Health Technol Assess 2001; 5:13-28.
  2. Ezechi, OC., Fasuba, OB., Dare, FO. Socioeconomic barrier to safe motherhood among booked patients in rural Nigerian communities. J Obstet Gynaec 2000; 20: 32-34.
  3. Chaim, W., Bashiri, A, Bar-David, J., Shoham-Vardi, I., Mazor, M. Prevalence and clinical significance of postpartum endometritis and wound infection. Infect Dis Obstet Gynecol 2000; 8: 77- 82.
  4. Killian, CA., Graffunder, EM., Vinciguerra, TJ., Venezia, RA. Risk factors for surgical-site infections following cesarean section. Infect Control Hosp Epidemiol 2001; 22: 613- 617.
  5. Johnson, A., Young, D., Reilly, J. Caesarean section surgical site infection surveillance. J Hosp Infect 2006; 64: 1-6.
  6. Webster, J. Post Caesarean wound infection: a review of the risk factors. Aust N Z J Obstet Gynaecol 1988; 28: 201-207.
  7. Gorbach, S., Bartlett, J., Blacklow, N. Surgical Site Infections. Infectious Diseases (3rdedtn). Lippincott Williams and Wilkins 2004; 823-829.
  8. Horan, TC., Gaynes, RP., Martone, WJ., Jarvis, WR., Emori, TG. CDC definitions of nosocomial surgical site infections: A modification of CDC definition of surgical wound infections. Infect Control Hosp Epidemol 1992; 13: 606-608.
  9. Reid VC, Hartmann KE, McMahon M, Fry EP. Vaginal preparation with povidone iodine and postcesarean infectious morbidity: a randomized controlled trial. Obstet Gynecol 2001;97:147–52.
  10. Obsorne NG, Wright RC. 1977. Effect of preoperative scrub on the bacterial flora of the end cervix and vagina. Obstetrics and Gynecology 50:145–151.
  11. Guzman MA, Prien SD, Blann DW. Post-cesarean related infection and vaginal preparation with povidone–iodine revisited. Primary Care Update for OB/GYNS. 2002;9(6):206-209.
  12. Starr RV, Zurawski J, Ismail M. Preoperative vaginal preparation with povidone-iodine and the risk of postcesarean endometritis. Obstetrics and gynecology. 2005;105(5 Pt 1):1024-1029.
  13. Eason E, Wells G, Garber G, Hemmings R, Luskey G, Gillett P et al.. 2004. Antisepsis for abdominal hysterectomy: a randomised controlled trial of povidone-iodine gel. British Journal of Obstetrics and Gynaecology 111:695–699.
  14. Haas, D.M., Morgan, S., Contreras, K. 2014. Vaginal preparation with antiseptic solution before cesarean section for preventing postoperative infections. Cochrane Database Syst Rev., 12.



Policy for Articles with Open Access:
Authors who publish with MedPulse International Journal of Gynaecology, (Print ISSN: 2579-0870) (Online ISSN: 2636-4719) agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.